Emily Dimango, MD
Enriched profileProfessor of Medicine; Director, Gunnar Esiason Adult Cystic Fibrosis Center; Advisory/Assistant Dean, Vagelos College of Physicians and Surgeons · Columbia University Irving Medical Center
Emily Dimango is Professor of Medicine; Director, Gunnar Esiason Adult Cystic Fibrosis Center; Advisory/Assistant Dean, Vagelos College of Physicians and Surgeons at Columbia University Irving Medical Center. OpenAlex indexes 118 publications with 7,851 citations (h-index 40); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Emily DiMango, MD, is Professor of Medicine at Columbia University Irving Medical Center / Vagelos College of Physicians and Surgeons (NewYork-Presbyterian). The public record shows 118 publications with 7,851 citations (h-index 40), centered on Cystic Fibrosis, Asthma. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 12 companies, 4 NIH-funded awards (2002–2026).
- Most recent indexed publication: 2021 · Orphanet journal of rare diseases
- Top research focus: Cystic Fibrosis
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Consultant
FDA Anesthesiology and Respiratory Therapy Devices advisory panel
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lung.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Ginger's Therapeutic Potential in Asthma
Sponsor: Emily DiMango, MD
- Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations
Sponsor: Columbia University
- Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma
Sponsor: Columbia University
Industry payments
Updated 27 Aug 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Baxter HealthcareProgram year20253 payments
- GlaxoSmithKline, LLC.Program year20252 payments
- Insmed, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
72.2%Corticosteroid34.5%Trelegy Ellipta50%Breo Ellipta30%Budesonide-Formoterol Fumarate5%Dulera5%Fluticasone Propionate4%Breztri Aerosphere3%Symbicort3%Part D<11 patientsbeta2-Adrenergic Agonist21.9%Albuterol Sulfate Hfa89%Ventolin Hfa11%Part D<11 patientsAnti-infectives
16.2%Macrolide Antimicrobial7.1%Azithromycin100%Part D≥47 patientsFluoroquinolone Antibacterial4.2%Levofloxacin100%Part D≥39 patientsMetabolism & gastrointestinal
9%Corticosteroid7.9%Prednisone100%Part D≥56 patientsAntidiarrheal microorganisms1.1%Pertzye100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- Ginger's therapeutic potential in asthma
Columbia University Health Sciences
FY2026$586,258R33AT012627 - Ginger's therapeutic potential in asthma
Columbia University Health Sciences
FY2019$311,577R61AT009989 - Ginger's therapeutic potential in asthma
Columbia University Health Sciences
FY2018$332,175R61AT009989
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Health Disparities among adults cared for at an urban cystic fibrosis program.
Orphanet journal of rare diseases
Article2021
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/emily-dimango-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Emily-DiMango-11992162
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
jerrycahill.com/podcast/cystic-fibrosis-podcast-187-the-pre-transplant-process
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jerrycahill.com ↗ - Facebook
facebook.com/columbiamed/videos/emily-dimango-md-director-of-columbiameds-gunnar-esiason-cystic-fibrosis-adult-p/3734644303462103
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - X / Twitter
x.com/ColumbiaMed/status/1870229406263763404
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
- Internship
Residency, and Fellowship, NewYork-Presbyterian Hospital/Columbia University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Board Certified
Pulmonary Disease Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
Editorial & leadership roles
journal and society appointments- Director
Columbia University Gunnar Esiason Adult Cystic Fibrosis Center (~300 CF patients)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Director
John Edsall/John Wood Asthma Center at Columbia University Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗ - Co-Director
Cystic Fibrosis Foundation Therapeutics Development Network at Columbia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.columbia.edu ↗
- Super Doctors2026provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.columbia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗
- Co-Director
Cystic Fibrosis Foundation Therapeutics Development Network at Columbia; National Chair, CFF TDN Program Protocol Review Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vagelos.columbia.edu ↗ - Principal Investigator
Airways Clinical Research Centers Network (American Lung Association), Columbia site
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center